Selected Balance Sheet Data (Tables)
|
9 Months Ended |
Mar. 31, 2022 |
Notes Tables |
|
Schedule of Inventory, Current [Table Text Block] |
Inventories consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2022 |
|
2021 |
Raw materials |
|
$ |
69,263 |
|
$ |
55,096 |
Finished goods(1) |
|
|
64,742 |
|
|
67,108 |
Inventories, net |
|
$ |
134,005 |
|
$ |
122,204 |
(1) Finished goods inventory of $5,722 and $5,456 included within other long-term assets in the respective March 31, 2022 and June 30, 2021, consolidated balance sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.
|
Property, Plant and Equipment [Table Text Block] |
Property and equipment consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2022 |
|
2021 |
Land |
|
$ |
8,603 |
|
$ |
8,612 |
Buildings and improvements |
|
|
225,378 |
|
|
190,661 |
Machinery and equipment |
|
|
164,665 |
|
|
149,410 |
Construction in progress |
|
|
26,508 |
|
|
49,073 |
Property and equipment, cost |
|
|
425,154 |
|
|
397,756 |
Accumulated depreciation and amortization |
|
|
(206,756) |
|
|
(189,849) |
Property and equipment, net |
|
$ |
218,398 |
|
$ |
207,907 |
|
Schedule of Intangible Assets and Goodwill [Table Text Block] |
Intangible assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2022 |
|
2021 |
|
|
|
|
|
|
|
Developed technology |
|
$ |
543,977 |
|
$ |
552,160 |
Trade names |
|
|
147,311 |
|
|
147,640 |
Customer relationships |
|
|
228,943 |
|
|
232,493 |
Patents |
|
|
3,249 |
|
|
2,926 |
Other intangibles |
|
|
6,313 |
|
|
6,316 |
Definite-lived intangible assets |
|
|
929,793 |
|
|
941,535 |
Accumulated amortization |
|
|
(401,151) |
|
|
(348,267) |
Definite-lived intangibles assets, net |
|
|
528,642 |
|
|
593,268 |
In process research and development |
|
|
22,700 |
|
|
22,700 |
Total intangible assets, net |
|
$ |
551,342 |
|
$ |
615,968 |
|
Schedule of Finite-Lived Intangible Assets [Table Text Block] |
Changes to the carrying amount of net intangible assets for the period ended March 31, 2022 consist of (in thousands):
|
|
|
|
|
|
|
|
Beginning balance |
|
$ |
615,968 |
Acquisitions |
|
|
— |
Other additions |
|
|
283 |
Amortization expense |
|
|
(55,731) |
Currency translation |
|
|
(615) |
Eminence impairment (1) |
|
|
(8,563) |
Ending balance |
|
$ |
551,342 |
|
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
The estimated future amortization expense for intangible assets as of March 31, 2022 is as follows (in thousands):
|
|
|
|
2022 remainder |
|
$ |
18,478 |
2023 |
|
|
71,725 |
2024 |
|
|
68,857 |
2025 |
|
|
65,621 |
2026 |
|
|
61,876 |
Thereafter |
|
|
242,085 |
Total |
|
$ |
528,642 |
(1) As disclosed in Note 1, the Company recorded an impairment charge of $8.6 million related to Eminence in Q2 of FY'22.
|
Schedule of Goodwill [Table Text Block] |
Changes to the carrying amount of goodwill for the period ended March 31, 2022 consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and |
|
|
|
|
Protein Sciences |
|
Genomics |
|
Total |
Beginning balance |
|
$ |
392,717 |
|
$ |
450,350 |
|
$ |
843,067 |
Acquisitions(1) |
|
|
— |
|
|
(4,407) |
|
|
(4,407) |
Eminence impairment |
|
|
(8,275) |
|
|
— |
|
|
(8,275) |
Currency translation |
|
|
(2,588) |
|
|
(179) |
|
|
(2,767) |
Ending balance |
|
$ |
381,854 |
|
$ |
445,764 |
|
$ |
827,618 |
|